How Blood Can Now Tell Us About Brain Health: Integration and Implementation of Blood Biomarkers for Alzheimer's Disease — Frontiers of BrainHealth Lecture

About this event

Free, Hybrid Event  ↗

How Blood Can Now Tell Us About Brain Health: Integration and Implementation of Blood Biomarkers for Alzheimer's Disease — Frontiers of BrainHealth Lecture

Melissa Petersen, PhD – Assistant Professor of Family Medicine and Osteopathic Manipulative Medicine, Texas College of Osteopathic Medicine at UNT Health

The use of blood biomarkers to detect Alzheimer's disease has advanced significantly in both capability and scope. As a result, the integration of such biomarkers into clinical practice and Alzheimer's disease clinical trials has become an increasingly important area of focus. Recently approved blood-based diagnostic tests are beginning to enter clinical settings, although guidance on their optimal use and implementation continues to evolve. Dr. Petersen's research presentation reviews the current landscape of blood biomarkers for Alzheimer's disease, including their context of use, clinical applications, limitations, and future directions. Her research interests include Alzheimer’s disease, biomarkers, plasma and Down syndrome.

Host: Lori Cook, PhD, CCC-SLP

Frontiers of BrainHealth is a hybrid speaker series. Register for the season, and you will get a link to the virtual talks as well as available recordings. If you are interested in attending any of the talks in person, please note that you can confirm attendance when we send you a reminder email a few days prior to each talk.

For more information,  visit our FAQs  or email  brainhealthevents@utdallas.edu .